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Introduction
• Kratom (Mitragyna speciosa) is an herb native to Southeast Asia with
opioid and stimulant-like properties that is commonly used to achieve
a legal recreational high.
• Kratom purchase and consumption is legal in most U.S. states.
• Cases of acute toxicity and withdrawal have been increasing over the
past decade.

Case Presentation
Pre-hospital course
• Well adjusted 38 y.o. male presented with respiratory arrest requiring
intubation by EMS in the field.
• Found to have pinpoint pupils and bradypnea that was minimally
responsive to naloxone.
ICU course
• Transferred to ICU and quickly extubated.
• 12 hours after arrival the patient became tachycardiac, tachypneic,
and developed a new tremor along with new visual hallucinations.
• Patient was reintubated due to progression of symptoms.
• Was restarted on his home dose of tramadol due to fear of withdrawal,
symptoms persisted.
• A Fentanyl drip provided minor improvement in his tremors and
hallucinations.

Case resolution
• On day 5, multiple empty bags of “Maeng Da”
tea were found in the patient’s home.
• Clonidine and hydroxyzine provided further
improvement in his anxiety, tremor, and
tachycardia.
• Extubated on day 9.
• Once stable, induction therapy with
buprenorphine was started and eventually
discharged on day 18.

Increasing use/abuse in U.S.

What is Kratom

Legality of Kratom

History
• Leaves were historically chewed by laborers in SE Asia to combat fatigue and to
help treat aches and pains.

• Kratom has a long history of abuse in SE Asia and is a controlled
substance in this region.
• The DEA is aware of the dangers of Kratom, however it is not
currently a scheduled substance.
• As of 2020, there are no federal laws prohibiting Kratom use.
Purchase and consumption is legal in most states.

Current uses
• Commonly used as an opium substitute to treat pain or to treat mood disorders.
• Also used to obtain a recreational high.

Increasing use/abuse in U.S.

Effects
• A low doses (1-5g) has stimulant effects causing increased alertness, stamina
and euphoria.
• At high doses (5-15 grams) kratom acts on μ and κ opioid receptors causing
increase euphoria, sedation, and analgesia.
• Effects begin 5-10 mins after use and last for 2-5 hours.

• Kratom use in the U.S. has been steadily increasing since 2010
which has caused in increase in the amount of cases of acute
toxicity and withdrawal.

Figure left: Annual number of Kratom exposures reported to poison control centers in the
the U.S. from 2011 through 2017

Kratom Withdrawal
• Withdrawal symptoms are common after discontinuing use following weeks to
months of daily use.
• Kratom withdrawal begins approximately 12 hours after last use.
• Duration of kratom withdrawal is similar to that opioid withdrawal.
Symptoms of Kratom withdrawal

Treatment

• There are no concrete guidelines on management of Kratom withdrawal,
however, multiple case reports have described successful treatment with
symptom-triggered clonidine & scheduled hydroxyzine during acute phase.
• Case reports have also described success with transitioning patients onto long
term buprenorphine-naloxone maintenance.

Learning Points
• Kratom is herb with opioid and stimulant-like properties which is legal
to buy and consume in most U.S. states.
• Cases of acute toxicity and withdrawal from kratom are becoming
increasingly common due to widespread availability in our community
• Many physicians are unaware of the effects of kratom and fail to ask
patients about their use of herbal medications.
• Kratom withdrawal is treatable with clonidine, hydroxyzine and
buprenorphine.
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